Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era | Circulation: Arrhythmia and Electrophysiology
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19 - ABC Cardiol
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 | JACC: Clinical Electrophysiology
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 - ScienceDirect
Azithromycin and the Risk of Cardiovascular Death | NEJM
The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients - Avedissian - 2019 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library
FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms
Myth-busting: Azithromycin does not cause torsade de pointes or increase mortality
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine- azithromycin combination regimen - International Journal of Cardiology
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine - HeartRhythm Case Reports
VisualAbstract: Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin | 2 Minute Medicine
Myth-busting: Azithromycin does not cause torsade de pointes or increase mortality
HCQ Plus Azithromycin: A Dangerous Combination? | MedPage Today
How to Diagnose and Manage QT Prolongation in Cancer Patients | JACC: CardioOncology
Hydroxychloroquine-Induced QT Prolongation in a COVID-19–Positive Patient on Clozapine | Psychiatrist.com
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin | Nature Medicine
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection - Mayo Clinic Proceedings
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 - ScienceDirect
Measurement and Management of QT Interval Prolongation for General Physicians | SpringerLink
Simplifying QT prolongation for busy clinicians | The College of Family Physicians of Canada
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients | Scientific Reports
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin | SpringerLink
QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia - Gumilang ...
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine
Cardiovascular Risks with Azithromycin and Other Antibacterial Drugs | NEJM
Clinical aspects of drug-induced QT prolongation
